JenniferLeaSeminerio-DiehlMD
Gastroenterology • Orlando, FLInflammatory Bowel Disease
Assistant Professor of Medicine at USF Health
Dr. Seminerio-Diehl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
265 E Rollins St Ste 10000
Orlando, FL 32804Phone+1 407-303-9921Fax+1 813-615-8008
Summary
- Dr. Jennifer Seminerio-Diehl is a gastroenterologist in Tampa, FL and is affiliated with Tampa General Hospital. She received her medical degree from University of Toledo College of Medicine and has been in practice 9 years. She specializes in inflammatory bowel disease.
Education & Training
UPMC Medical EducationFellowship, Gastroenterology, 2011 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2008 - 2011
The University of Toledo College of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2017 - 2027
SC State Medical License 2014 - 2019
PA State Medical License 2011 - 2014
MN State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 1 citationsExploring Dual-Targeted Therapy in the Management of Moderate to Severe Inflammatory Bowel Disease: A Retrospective Study.Sonya Bhaskar, Zachary Makovich, Rahul Mhaskar, Emily Coughlin, Jennifer Seminerio-Diehl
Crohn's & Colitis 360. 2025-01-01 - Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.Hans H Herfarth, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Clinical and Translational Gastroenterology. 2024-03-01 - 15 citationsTofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.Millie D Long, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Inflammatory Bowel Diseases. 2023-04-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
